RIMAG GROUP (02522) saw its stock price soar by 13.62% during intraday trading on Monday, as investors eagerly anticipate the company's upcoming interim results. The medical imaging service provider is set to release its first-half earnings report after the market close, with expectations of substantial growth in both revenue and net profit.

According to the company's previous forecast, RIMAG GROUP expects to report first-half revenue between RMB 450-480 million, representing a year-on-year increase of 8.77% to 16.03%. More impressively, net profit is projected to range from RMB 14.5 million to RMB 16.5 million, marking a remarkable year-on-year growth of approximately 1,350% to 1,550%. The significant improvement in profitability is attributed to the expansion of the company's customer base, increased service delivery, and a reduction in administrative expenses.

Analysts have highlighted RIMAG GROUP's position as a leading domestic medical imaging service provider with steady expansion. The company's focus on developing comprehensive smart imaging solutions and establishing pathways for data monetization in the AI era has contributed to its positive outlook. As of the latest trading update, RIMAG GROUP's stock was up 11.61% at HK$22.2, with a substantial trading volume of HK$1.016 billion, reflecting strong investor interest ahead of the earnings announcement.